Prelude Therapeutics Inc. (PRLD): Price and Financial Metrics Recent IPO

Prelude Therapeutics Inc. (PRLD) Recent IPO

Today's Latest Price: $46.91 USD

1.73 (-3.56%)

Updated Nov 24 4:00pm

Add PRLD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PRLD Stock Price Chart Interactive Chart >

Price chart for PRLD

PRLD Price/Volume Stats

Current price $46.91 52-week high $57.67
Prev. close $48.64 52-week low $23.69
Day low $46.30 Volume 102,200
Day high $51.32 Avg. volume 180,167
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 2.05B

Prelude Therapeutics Inc. (PRLD) Company Bio

Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

PRLD Latest News Stream

Event/Time News Detail
Loading, please wait...

PRLD Latest Social Stream

Loading social stream, please wait...

View Full PRLD Social Stream

Latest PRLD News From Around the Web

Below are the latest news stories about Prelude Therapeutics Inc that investors may wish to consider to help them evaluate PRLD as an investment opportunity.

Prelude Therapeutics opens 32.8% above its IPO price

Prelude Therapeutics (PRLD) has opened at $25.23, 32.8% well above IPO price of $19.The company raised $158.2M by selling 8.325M shares.Previously: Prelude Therapeutics prices IPO at $19, higher end of expected range of $17-$19 (Sept. 25)...

Seeking Alpha | September 25, 2020

Prelude Therapeutics prices IPO at $19, higher end of expected range of $17-$19

Biotech startup, Prelude Therapeutics (PRLD) has priced its initial public offering of 8.325M shares at $19/share, for expected gross proceeds of ~$158.2M.Underwriters' over-allotment is an additional 1,248,750 shares. Shares to kick-off trading today on the Nasdaq Global Select Market.Offering is expected to close on September 29, 2020.The Wilmington, DE-based biotech leverages...

Seeking Alpha | September 25, 2020

Read More 'PRLD' Stories Here

PRLD Price Returns

1-mo 45.01%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7451 seconds.